醫療圖像用試劑與分析裝置 是由出版商BCC Research在2010年01月所出版的。
這份英文市場調查報告書包含138 pages 價格從美金4850起跳。
本報告內容為，檢討醫療圖像用試劑與分析裝置的市場，2008及2009年的銷售成績數據，到2014年的成長率，MRI或超音波及CT這些既有的醫療圖像方法的概要，主要參與市場企業近年的專利方向，新技術的開方向等等資料。重點條目如下。
第1章 緒論
第2章 綱要
第3章 概述
- 什麼是醫療圖像
- 醫療圖像的歷史
- 醫療圖像的種類
- 各種技術的差異
- 造影劑還是圖像試劑
- 圖像設備
- X裝設備
- 螢光設備
- CT掃描器
- 超音波設備
- MRI設備
- PET設備
第4章 法規蓋述
- CT
- 超音波
- PET
- 現在GM條件的變更必要性
- 醫療圖像分野的確立
第5章 業界構造
- 造影劑/圖像試劑的製造業者以及製品
- 圖像設備的製造業者以及製品
- 業界領導的共同市場
第6章 新規格的開發
第7章 市場
- 造影劑/圖像試劑
- X光與CT用造影劑
- 超音波用造影劑
- MRI造影劑
- 放射性藥品
- 圖像設備
第8章 各種用途的市場
- 各種用途的市場規模
- 心血管疾病的診斷
- 癌症的診斷
- 中樞神經系統疾病的診斷
- 腸胃病診斷
- 其他
第9章 專利分析
- 專利分析
- 年分別專利
- 種類別專利
- 企業別專利
- 國別專利
第10章 圖像市場的現況
- 造影劑市場的現況
- 影響圖像市場的主因
- 法規
- 高齡化
- 競爭
- 技術進歩
- 目前業界的問題
第11章 企業資料
Abstract
Highlights
THIS REPORT
- Examine the supporting products that have enhanced imaging at the chemical
level (reagents and contrast media) and at the analysis level (software tools
and image management)
- Provide market data for 2008 and 2009, and forecast the compound annual
growth rate (CAGR) for the period 2009-2014
- Explain how existing medical imaging modalities such as magnetic resonance
imaging (MRI), ultrasound, computed tomography (CT), and nuclear medicine are
finding new applications through the development of specialized imaging
reagents
- Assess the major medical applications, market players, recent patents, and
emerging technologies in reagents, analysis, and image management
Scope & Analyst
INTRODUCTION
STUDY OBJECTIVES
BCC' s goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for medical imaging. The key
objective is to present a comprehensive analysis of the current market and its
future direction as an important tool for the diagnosis of various diseases.
This report explores present and future strategies within the imaging market,
including reagents, equipment and systems used for imaging. The improvisation
of the market, its setbacks and needs are discussed in this report.
Comparisons, usage and the advantages and disadvantages of each imaging system
are also discussed in this report.
A detailed analysis of the imaging industry structure has been conducted. This
includes both the imaging reagents and the equipment used. Revenues are broken
down by region. Sales figures are estimated for the 5 year period from 2009
through 2014.
Applications for imaging are also discussed separately in the report, with
emphasis on its usage in cardiovascular, oncology, gastrointestinal and
central nervous system diseases. The report also covers significant patents
and their allotment in each category.
REASONS FOR DOING THIS STUDY
Medical imaging has seen major advances in modern medicine.The "compact
revolution" is changing the market of imaging systems. R&D spending, along
with increasing competition, patent expiries, new technologies, and an
international marketplace are sending the market in new directions. Although
the industry did see some setbacks in 2008 due to the economic downturn, new
advancements and the need for diagnosis through imaging are helping the market
to grow. This study looks at many of the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in
this report. This study also discusses the strength and weaknesses of each
system/ technology in light of new technologies, growing competition, and
changing customer needs.
INTENDED AUDIENCE
This study contributes to the areas of market growth in diagnosis through
imaging from the point of view of manufacturers and users. Analytical
companies, physicians, the pharmaceutical and biopharmaceutical industries,
hospitals and research institutes will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the imaging, diagnosing and medical
markets. BCC analyzes each market and its applications by its need for
diagnosis through imaging, regulatory environment, technology involved, market
projections, and market share. Technological issues include the latest trends
and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in this study. BCC
conducted a comprehensive literature search, which included technical
newsletters and journals, and many other sources. Data were collected through
interviews and correspondence with various analytical, chemical,
pharmaceutical, and biotechnical experts. Projections were based on estimates
such as the current number of end users, potential end users, mergers and
acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this
study. Included were manufacturers and end users of pharmaceuticals through
contract manufacturing and research. Data were gathered from various industry
sources. BCC spoke with officials and physicians within the industry,
consulted newsletters, company literature, product literature, and a host of
technical articles, journals, indexes, and abstracts. Exhaustive
investigations of databases by key terminology were completed. In addition,
data were compiled from current financial, trade, and government sources.
Table of Contents
Chapter- 1: INTRODUCTION -- Complimentary 3
- STUDY OBJECTIVES 1
- REASONS FOR DOING THIS STUDY 1
- INTENDED AUDIENCE 2
- SCOPE OF THE STUDY 2
- METHODOLOGY 2
- INFORMATION SOURCES 2
- ABOUT THE AUTHOR 2
- RELATED BCC RESEARCH REPORTS 3
- BCC ONLINE SERVICES 3
- DISCLAIMER 3
Chapter-2: SUMMARY 3
- SUMMARY 4
- SUMMARY TABLE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND
SYSTEMS), THROUGH 2014 ($ MILLIONS) 5
- SUMMARY FIGURE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND
SYSTEMS), 2007-2014 ($ MILLIONS) 6
Chapter-3: OVERVIEW 19
- WHAT IS MEDICAL IMAGING 7
- HISTORY OF MEDICAL IMAGING 7
- TABLE 1 HISTORY OF MEDICAL IMAGING, 1895-1993 7
- TYPES OF MEDICAL IMAGING 8
- X-RAY IMAGING 8
- Applications of X-ray in Medicine 8
- TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY IMAGING 9
- ULTRASOUND 9
- Applications of Ultrasound 9
- TABLE 3 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 10
- MAGNETIC RESONANCE IMAGING 10
- Applications of Magnetic Resonance Imaging 11
- TABLE 4 ADVANTAGES AND DISADVANTAGES OF MAGNETIC RESONANCE IMAGING 11
- COMPUTED TOMOGRAPHY 12
- Applications of Computed Tomography 12
- TABLE 5 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 13
- POSITRON EMISSION TOMOGRAPHY 13
- Applications of Positron Emission Tomography 14
- TABLE 6 ADVANTAGES AND DISADVANTAGES OF POSITRON EMISSION TOMOGRAPHY 14
- DIFFERENTIATION BETWEEN VARIOUS IMAGING TECHNIQUES 15
- TABLE 7 DIFFERENCES BETWEEN CT AND PET 15
- TABLE 8 DIFFERENCES BETWEEN CT AND MRI 15
- CONTRAST AGENTS OR IMAGING REAGENTS 15
- PROPERTIES OF AN IDEAL CONTRAST AGENT 16
- CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES 16
- Positive Contrast Agents 16
- Barium 16
- Iodine-based Contrast Agents 17
- Negative Contrast Agents 17
- CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING TECHNIQUE 17
- Contrast Agents for X-Ray 18
- Contrast Agents for Magnetic Resonance Imaging 18
- Contrast Agents for Ultrasound 19
- PET Radiopharmaceuticals 19
- TABLE 9 COMPOUNDS USED IN PET SCAN 20
- IMAGING EQUIPMENT 20
- X-RAY IMAGING SYSTEM 20
- FLUOROSCOPY EQUIPMENT 21
- COMPUTED TOMOGRAPHY SCANNER 21
- ULTRASOUND MACHINES 22
- Bedside Doppler 23
- Duplex Doppler 23
- Color Doppler 23
- Power Doppler 23
- MAGNETIC RESONANCE IMAGING SYSTEM 24
- Conventional MRI Units 24
- Short-bore MRI Units 25
- Open MRI Units 25
- Mobile MRI Units 25
- Dedicated Extremity/Head/Breast MRI units 25
- POSITRON EMISSION TOMOGRAPHY EQUIPMENT 25
Chapter-4: REGULATORY ASPECTS 4
- COMPUTED TOMOGRAPHY 26
- ULTRASOUND 27
- POSITRON EMISSION TOMOGRAPHY 27
- NEED FOR CHANGE IN CURRENT GOOD MANUFACTURING PRACTICES REQUIREMENTS 28
- APPROVALS IN THE FIELD OF MEDICAL IMAGING 28
- TABLE 10 APPROVALS OF IMAGING AGENTS: 2006 THROUGH SEPTEMBER 2009 28
- TABLE 11 APPROVALS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29
- TABLE 12 RECALLS OF IMAGING REAGENTS: 2006 THROUGH SEPTEMBER 2009 29
- TABLE 13 RECALLS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29
Chapter-5: INDUSTRY STRUCTURE 20
- MANUFACTURERS/ PRODUCTS FOR CONTRAST AGENTS/ IMAGING REAGENTS 30
- TABLE 14 LEADING MANUFACTURERS OF X-RAY AND COMPUTED TOMOGRAPGY CONTRAST
AGENTS 30
- TABLE 14 (CONTINUED) 31
- TABLE 15 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS 31
- TABLE 16 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST
AGENTS 31
- TABLE 16 (CONTINUED) 32
- TABLE 17 LEADING MANUFACTURERS OF RADIOPHARMACEUTICALS 32
- TABLE 17 (CONTINUED) 33
- TABLE 17 (CONTINUED) 34
- MANUFACTURERS/ PRODUCTS FOR IMAGING SYSTEMS/ EQUIPMENT 34
- TABLE 18 LEADING MANUFACTURERS OF RADIOGRAPHY (X-RAY, FLUOROSCOPY AND
MAMMOGRAPHY) IMAGING SYSTEMS 34
- TABLE 18 (CONTINUED) 35
- TABLE 19 LEADING MANUFACTURERS OF COMPUTED TOMOGRAPHY SYSTEMS 36
- TABLE 20 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS 36
- TABLE 20 (CONTINUED) 37
- TABLE 20 (CONTINUED) 38
- TABLE 21 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING SYSTEMS 39
- TABLE 22 LEADING MANUFACTURERS OF POSITRON EMISSION TOMOGRAPHY SYSTEMS 40
- MARKET SHARES OF INDUSTRY LEADERS 40
- CONTRAST AGENTS/ IMAGING REAGENTS 40
- X-Ray and Computed Tomography Reagents 40
- TABLE 23 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST
AGENTS, 2009 (%) 41
- FIGURE 1 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST
AGENTS, 2009 (%) 41
- Ultrasound Contrast Agents 42
- TABLE 24 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 42
- FIGURE 2 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 (%) 42
- Magnetic Resonance Imaging Agents 43
- TABLE 25 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST
AGENTS, 2009 (%) 43
- FIGURE 3 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST
AGENTS, 2009 (%) 43
- Radiopharmaceuticals 44
- TABLE 26 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44
- FIGURE 4 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44
- IMAGING SYSTEMS/ EQUIPMENT 45
- X-Ray Imaging Systems 45
- TABLE 27 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45
- FIGURE 5 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45
- Computed Tomography Imaging Systems 46
- TABLE 28 GLOBAL MARKET SHARES OF COMPUTED TOMOGRAPHY IMAGING SYSTEMS, 2009
(%) 46
- FIGURE 6 GLOBAL MARKET SHARES OF COMPUTED X-RAY IMAGING SYSTEMS, 2009 (%)
46
- Ultrasound Imaging Systems 47
- TABLE 29 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47
- FIGURE 7 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47
- Magnetic Resonance Imaging Systems 48
- TABLE 30 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009
(%) 48
- FIGURE 8 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009
(%) 48
- Positron Emission Tomography Imaging Systems 49
- TABLE 31 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY SYSTEMS,
2009 49
- FIGURE 9 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY IMAGING
SYSTEMS, 2009 (%) 49
Chapter-6: NEW DEVELOPMENTS 5
- IMAGING REAGENTS/ CONTRAST AGENTS 55
- X-RAY AND CT CONTRAST AGENTS 55
- Market Overview 55
- Market Revenue 56
- TABLE 37 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, THROUGH
2014 ($ MILLIONS) 56
- FIGURE 10 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION,
2007-2014 ($ MILLIONS) 57
- Market Shares 57
- TABLE 38 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 58
- FIGURE 11 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION,
2009 (%) 58
- ULTRASOUND CONTRAST AGENTS 58
- Market Overview 59
- Market Revenue 60
- TABLE 39 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, THROUGH
2014 ($ MILLIONS) 60
- FIGURE 12 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION,
2007-2014 ($ MILLIONS) 60
- Market Share 61
- TABLE 40 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 61
- FIGURE 13 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 62
- MRI CONTRAST AGENTS 62
- Market Overview 62
- Market Overview (Continued) 63
- Market Revenue 64
- TABLE 41 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE CONTRAST AGENTS BY
REGION, THROUGH 2014 ($ MILLIONS) 64
- FIGURE 14 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS BY
REGION, 2007-2014 ($ MILLIONS) 64
- Market Share 65
- TABLE 42 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES
BY REGION, 2009 (%) 65
- FIGURE 15 GLOBAL MAGENTIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES
BY REGION, 2009 (%) 65
- RADIOPHARMACEUTICALS 66
- Market Overview 66
- Market Revenue 67
- TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, THROUGH 2014 ($
MILLIONS) 67
- FIGURE 16 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, 2007-2014 ($
MILLIONS) 67
- Market Share 68
- TABLE 44 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
- FIGURE 17 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
- IMAGING SYSTEMS/ EQUIPMENT 69
- X-RAY IMAGING SYSTEMS 69
- Market Overview 69
- Market Revenue 70
- TABLE 45 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, THROUGH 2014
($ MILLIONS) 70
- FIGURE 18 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, 2007-2014 ($
MILLIONS) 70
- Market Share 71
- TABLE 46 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
- FIGURE 19 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
- COMPUTED TOMOGRAPHY IMAGING SYSTEMS 72
- Market Overview 72
- Market Revenue 73
- TABLE 47 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 73
- FIGURE 20 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY
REGION, 2007-2014 ($ MILLIONS) 73
- Market Share 74
- TABLE 48 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 74
- FIGURE 21 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 74
- ULTRASOUND IMAGING SYSTEMS 75
- Market Overview 75
- Market Revenue 76
- TABLE 49 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, THROUGH
2014 ($ MILLIONS) 76
- FIGURE 22 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION,
2007-2014 ($ MILLIONS) 76
- Market Share 77
- TABLE 50 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009
(%) 77
- FIGURE 23 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009
(%) 77
- MAGNETIC RESONANCE IMAGING SYSTEMS 78
- Market Overview 78
- Market Revenue 79
- TABLE 51 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 79
- FIGURE 24 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 79
- Market Share 80
- TABLE 52 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 80
- FIGURE 25 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 80
- POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS 80
- Market Overview 81
- Market Revenue 82
- TABLE 53 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY
REGION THROUGH 2014 ($ MILLIONS) 82
- FIGURE 26 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS
BY REGION, 2007-2014 ($ MILLIONS) 82
- Market Share 83
- TABLE 54 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES
BY REGION, 2009 (%) 83
- FIGURE 27 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET
SHARES BY REGION, 2009 (%) 83
Chapter-7: MARKETS 29
- IMAGING REAGENTS/ CONTRAST AGENTS 55
- X-RAY AND CT CONTRAST AGENTS 55
- Market Overview 55
- Market Revenue 56
- TABLE 37 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, THROUGH
2014 ($ MILLIONS) 56
- FIGURE 10 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION,
2007-2014 ($ MILLIONS) 57
- Market Shares 57
- TABLE 38 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 58
- FIGURE 11 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION,
2009 (%) 58
- ULTRASOUND CONTRAST AGENTS 58
- Market Overview 59
- Market Revenue 60
- TABLE 39 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, THROUGH
2014 ($ MILLIONS) 60
- FIGURE 12 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION,
2007-2014 ($ MILLIONS) 60
- Market Share 61
- TABLE 40 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 61
- FIGURE 13 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009
(%) 62
- MRI CONTRAST AGENTS 62
- Market Overview 62
- Market Overview (Continued) 63
- Market Revenue 64
- TABLE 41 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE CONTRAST AGENTS BY
REGION, THROUGH 2014 ($ MILLIONS) 64
- FIGURE 14 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS BY
REGION, 2007-2014 ($ MILLIONS) 64
- Market Share 65
- TABLE 42 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES
BY REGION, 2009 (%) 65
- FIGURE 15 GLOBAL MAGENTIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES
BY REGION, 2009 (%) 65
- RADIOPHARMACEUTICALS 66
- Market Overview 66
- Market Revenue 67
- TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, THROUGH 2014 ($
MILLIONS) 67
- FIGURE 16 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, 2007-2014 ($
MILLIONS) 67
- Market Share 68
- TABLE 44 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
- FIGURE 17 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68
- IMAGING SYSTEMS/ EQUIPMENT 69
- X-RAY IMAGING SYSTEMS 69
- Market Overview 69
- Market Revenue 70
- TABLE 45 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, THROUGH 2014
($ MILLIONS) 70
- FIGURE 18 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, 2007-2014 ($
MILLIONS) 70
- Market Share 71
- TABLE 46 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
- FIGURE 19 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71
- COMPUTED TOMOGRAPHY IMAGING SYSTEMS 72
- Market Overview 72
- Market Revenue 73
- TABLE 47 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 73
- FIGURE 20 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY
REGION, 2007-2014 ($ MILLIONS) 73
- Market Share 74
- TABLE 48 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 74
- FIGURE 21 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 74
- ULTRASOUND IMAGING SYSTEMS 75
- Market Overview 75
- Market Revenue 76
- TABLE 49 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, THROUGH
2014 ($ MILLIONS) 76
- FIGURE 22 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION,
2007-2014 ($ MILLIONS) 76
- Market Share 77
- TABLE 50 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009
(%) 77
- FIGURE 23 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009
(%) 77
- MAGNETIC RESONANCE IMAGING SYSTEMS 78
- Market Overview 78
- Market Revenue 79
- TABLE 51 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 79
- FIGURE 24 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION,
THROUGH 2014 ($ MILLIONS) 79
- Market Share 80
- TABLE 52 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 80
- FIGURE 25 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY
REGION, 2009 (%) 80
- POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS 80
- Market Overview 81
- Market Revenue 82
- TABLE 53 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY
REGION THROUGH 2014 ($ MILLIONS) 82
- FIGURE 26 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS
BY REGION, 2007-2014 ($ MILLIONS) 82
- Market Share 83
- TABLE 54 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES
BY REGION, 2009 (%) 83
- FIGURE 27 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET
SHARES BY REGION, 2009 (%) 83
Chapter-8: MARKET BY APPLICATIONS 15
- MARKET SHARE OF APPLICATIONS 84
- TABLE 55 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85
- FIGURE 28 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85
- CARDIOVASCULAR DISEASE DIAGNOSIS 85
- MARKET REVENUE 86
- TABLE 56 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CARDIOVASCULAR
DISEASES, THROUGH 2014 ($ MILLIONS) 86
- FIGURE 29 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF
CARDIOVASCULAR DISEASES, 2007-2014 ($ MILLIONS) 87
- MARKET SHARE 87
- TABLE 57 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF
CARDIOVASCULAR DISEASES, 2009 (%) 87
- FIGURE 30 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF
CARDIOVASCULAR DISEASES, 2009 (%) 88
- ONCOLOGY DISEASE DIAGNOSIS 88
- MARKET REVENUE 89
- TABLE 58 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, THROUGH
2014 ($ MILLIONS) 89
- FIGURE 31 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER,
2007-2014 ($ MILLIONS) 90
- MARKET SHARE 90
- TABLE 59 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER,
2009 (%) 90
- FIGURE 32 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER,
2009 (%) 91
- CENTRAL NERVOUS SYSTEM DIAGNOSIS 91
- MARKET REVENUE 92
- TABLE 60 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS
SYSTEM DISEASES, THROUGH 2014 ($ MILLIONS) 92 FIGURE 33 GLOBAL REVENUE FOR
IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2007-2014 ($
MILLIONS) 93
- MARKET SHARE 93
- TABLE 61 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL
NERVOUS SYSTEM DISEASES, 2009 (%) 93
- FIGURE 34 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL
NERVOUS SYSTEM DISEASES, 2009 (%) 94
- GASTROINTESTINAL (GI) SYSTEM DIAGNOSIS 94
- MARKET REVENUE 95
- TABLE 62 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL
DISEASES, THROUGH 2014 ($ MILLIONS) 95
- FIGURE 35 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF
GASTROINTESTINAL DISEASES, 2007-2014 ($ MILLIONS) 95
- MARKET SHARE 96
- TABLE 63 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF
GASTROINTESTINAL DISEASES, 2009 (%) 96
- FIGURE 36 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF
GASTROINTESTINAL DISEASES, 2009 (%) 96
- OTHERS 97
- MARKET REVENUE 97
- TABLE 64 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER
DISEASES, THROUGH 2014 ($ MILLIONS) 97
- FIGURE 37 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER
DISEASES, 2007-2014 ($ MILLIONS) 97
- MARKET SHARE 98
- TABLE 65 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER
DISEASES, 2009 (%) 98
- FIGURE 38 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER
DISEASES, 2009 (%) 98
Chapter-9: PATENT ANALYSIS 14
- PATENT ANALYSIS 99
- PATENTS BY YEAR 99
- TABLE 66 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 100
- FIGURE 39 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 (NUMBER) 100
- FIGURE 40 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, 2005-2009 (%) 101
- PATENTS BY TYPE 101
- TABLE 67 PATENTS BY TYPE FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 102
- FIGURE 41 PATENTS BY TYPE OF CONTRAST AGENT, 2005-2009 (NUMBER) 102
- TABLE 68 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103
- FIGURE 42 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103
- PATENTS BY COMPANY 103
- TABLE 69 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009
(NUMBER) 104
- FIGURE 43 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009
(NUMBER) 104
- TABLE 70 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009
105
- FIGURE 44 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009
106
- PATENTS BY COUNTRY 106
- TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009
107
- FIGURE 45 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009
107
- TABLE 72 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108
- FIGURE 46 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108
- TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009
109
- FIGURE 47 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009
109
- TABLE 74 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110
- FIGURE 48 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110
- PATENTS BY ASSIGNEE 110
- TABLE 75 NUMBER OF PATENTS BY ASIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009
111
- FIGURE 49 NUMBER OF PATENTS BY ASSGINEE TYPE FOR CONTRAST AGENTS,
2005-2009 111
- TABLE 76 PATENTS BY ASSIGMEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112
- FIGURE 50 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112
Chapter-10: CURRENT SITUATION OF IMAGING MARKET 5
- CONTRAST AGENT MARKET SITUATION 113
- IMAGING SYSTEMS MARKET SITUATION 113
- IMAGING SYSTEMS MARKET ... (CONTINUED) 114
- IMAGING SYSTEMS MARKET ... (CONTINUED) 115
- FACTORS AFFECTING THE IMAGING MARKET 116
- REGULATORY ACTIONS 116
- AGING POPULATION 116
- COMPETITION 116
- TECHNOLOGICAL ADVANCEMENTS 117
- SETBACKS IN INDUSTRY 117
Chapter-11: COMPANY PROFILES 21
- ALOKA CO. LTD. 118
- AMAG PHARMACEUTICALS INC. 118
- ANALOGIC CORPORATION 119
- BAYER HEALTHCARE PHARMACEUTICALS 119
- COVIDIEN 120
- ECHOSON SA (PL) 121
- ESAOTE S.P.A 121
- E-Z-EM INC 122
- FONAR CORPORATION 122
- GE HEALTHCARE MEDICAL DIAGNOSTICS 123
- GUERBET LLC 124
- HITACHI MEDICAL SYSTEMS AMERICA INC 124
- HOLOGIC INC 125
- IN VIVO CORPORATION 125
- LANTHEUS MEDICAL IMAGING 126
- BLDG. 200-2 126
- MALLINCKRODT 126
- MDS NORDION 127
- MEDISON AMERICA INC 127
- MILLENIUM TECHNOLOGIES LTD. 128
- ONI MEDICAL SYSTEMS INC. 128
- PARADIGM MEDICAL INDUSTRIES 129
- PARAMED MEDICAL SYSTEMS INC. 129
- PHILIPS HEALTHCARE 129
- POSITRON CORPORATION 130
- SHIMADZU CORPORATION 131
- SIEMENS AG 131
- SONOSITE INC 132
- TELEMED LTD. 133
- TERASON ULTRASOUND 133
- TIME MEDICAL INC 134
- TOMTEC IMAGING SYSTEMS 134
- TOSHIBA AMERICA INC 135
- TRIAD ISOTOPES INC 135
- ULTRASONIX MEDICAL CORP. 136
- VOLCANO CORPORATION 137
- ZONARE MEDICAL SYSTEMS INC. 137
APPENDIX: ABBREVIATIONS 138
|
